NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025.
1/5 보강
The treatment landscape for soft tissue sarcomas (STS) is evolving constantly.
APA
von Mehren M, Kane JM, et al. (2025). NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025.. Journal of the National Comprehensive Cancer Network : JNCCN, 23(12), 498-506. https://doi.org/10.6004/jnccn.2025.0058
MLA
von Mehren M, et al.. "NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025.." Journal of the National Comprehensive Cancer Network : JNCCN, vol. 23, no. 12, 2025, pp. 498-506.
PMID
41671462 ↗
Abstract 한글 요약
The treatment landscape for soft tissue sarcomas (STS) is evolving constantly. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for STS specific to surgical management and systemic therapy recommendations for various subtypes.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.